Favipiravir Induced Acute Pancreatitis in a COVID-19 Patient
Journal of Medicine
; 22(1):69-71, 2021.
Article
in English
| ProQuest Central | ID: covidwho-1060535
ABSTRACT
There are a number of gastrointestinal symptoms and complications of COVID-19. Asymptomatic increase in pancreatic enzymes and rarely symptomatic pancreatitis are observed in this disease. This article describes a 37-year-old male suffering from mildly symptomatic COVID-19 infection, who received tablet favipiravir for his management. His condition was improving, when he developed acute pancreatitis, diagnosed clinically, biochemically and also with help of abdominal ultrasound. When he developed this, all typical symptoms of COVID-19 were improved. As a result, role of favipiravir in the development of this pancreatitis was suspected.
Full text:
Available
Collection:
Databases of international organizations
Database:
ProQuest Central
Language:
English
Journal:
Journal of Medicine
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS